PCG
REGN icon

Private Capital Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Private Capital Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$4K Hold
7
– – ﹤0.01% 1354
2022
Q1 		$5K Sell
7
-1
-13% -$633 ﹤0.01% 1532
2021
Q4 		$5K Sell
8
-12
-60% -$7.38K ﹤0.01% 1560
2021
Q3 		$12K Hold
20
– – ﹤0.01% 1277
2021
Q2 		$11K Buy
20
+9
+82% +$4.56K ﹤0.01% 1309
2021
Q1 		$5K Sell
11
-3
-21% -$1.46K ﹤0.01% 1519
2020
Q4 		$7K Sell
14
-2
-13% -$1.08K ﹤0.01% 1489
2020
Q3 		$9K Buy
16
+9
+129% +$5.46K ﹤0.01% 1356
2020
Q2 		$4K Hold
7
– – ﹤0.01% 1565
2020
Q1 		$3K Hold
7
– – ﹤0.01% 1614
2019
Q4 		$2K Hold
7
– – ﹤0.01% 1718
2019
Q3 		$2K Sell
7
-42
-86% -$12.4K ﹤0.01% 1916
2019
Q2 		$17K Buy
49
+32
+188% +$10.7K ﹤0.01% 1155
2019
Q1 		$7K Sell
17
-2
-11% -$824 ﹤0.01% 1578
2018
Q4 		$7K Sell
19
-14
-42% -$5.12K ﹤0.01% 1528
2018
Q3 		$13K Sell
33
-16
-33% -$6.09K ﹤0.01% 1351
2018
Q2 		$16K Sell
49
-7
-13% -$2.19K ﹤0.01% 1215
2018
Q1 		$19K Sell
56
-1,444
-96% -$502K ﹤0.01% 1096
2017
Q4 		$73K Buy
+1,500
New +$607K 0.02% 531

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Private Capital Group's REGN Position: Q2 2022 in Review

Private Capital Group held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2022 at 7 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1354.

Private Capital Group first reported a position in REGN in Q4 2017 and has held it in 19 quarters since. The position peaked at $73K in Q4 2017. 1,064 funds tracked by Wall St. Rank hold REGN as of Q2 2022.

  • Private Capital Group held 7 shares of Regeneron Pharmaceuticals worth $4K as of Q2 2022.
  • Private Capital Group left its Regeneron Pharmaceuticals share count unchanged in Q2 2022.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #1354 holding.
  • Private Capital Group first reported a position in Regeneron Pharmaceuticals in Q4 2017 and has held it in 19 quarters since.
  • Private Capital Group's Regeneron Pharmaceuticals position peaked at $73K in Q4 2017.
  • 1,064 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.